A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence. 刊物 A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence. Explore how brand and generics show similar exposure but different absorption timing using Phoenix NLME.Certara2022 年 5 月 21 日
Comparative clinical study of the pharmacokinetics and bioequivalence of the combined drug Mioreol and the combined use of mono-drugs containing donepezil and memantine Publication Comparative clinical study of the pharmacokinetics and bioequivalence of the combined drug Mioreol and the combined use of mono-drugs containing donepezil and memantine Discover how linear PK up to 600 mg; saturation at 800 mg; PK modelled using…Certara2022 年 5 月 13 日
Population PK of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration Publication Population PK of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration See how CVVH reduces AUC three‑fold; simulations support 200 mg load + 150 mg q12h…Certara2022 年 5 月 5 日
Population Pharmacokinetics of Oral-Based Administration of Cannabidiol in Healthy Adults: Implications for Drug Development Publication Population Pharmacokinetics of Oral-Based Administration of Cannabidiol in Healthy Adults: Implications for Drug Development See how uncovered large inter‑individual variability in CBD pharmacokinetics, showing 3.6‑fold exposure differences and long…Certara2022 年 4 月 19 日
Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease Publication Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease Discover how evaluated ferric pyrophosphate citrate pharmacokinetics and safety in healthy and hemodialysis‑dependent CKD patients…Certara2022 年 4 月 5 日
Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms Publication Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms Explore how CYP2C9 and OATP1B1 genetic effects on torsemide PK in healthy Korean males, supporting…Certara2022 年 4 月 1 日
Co-Administration with Voriconazole Doubles the Exposure of Ruxolitinib in Patients with Hematological Malignancies Publication Co-Administration with Voriconazole Doubles the Exposure of Ruxolitinib in Patients with Hematological Malignancies Find out how voriconazole more than doubles ruxolitinib exposure, supporting dose adjustment guidance for hematologic…Certara2022 年 3 月 25 日
Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice Publication Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice See how major PK and metabolic differences between primaquine enantiomers, informing safer and more effective…Certara2022 年 2 月 5 日
Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang® SR and Glucophage® XR) Under Fed Conditions in Healthy Chinese Adult Subjects: An Open-Label, Two-Way Crossover, Sequence Randomized Phase I Clinical Trial Publication Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang® SR and Glucophage® XR) Under Fed Conditions in Healthy Chinese Adult Subjects: An Open-Label, Two-Way Crossover, Sequence Randomized Phase I Clinical Trial Learn how the confirmed bioequivalence of metformin SR formulations under fed conditions, with matched PK…Certara2022 年 1 月 21 日